Haploidentical SCT in children: an update and future perspectives (Q37315395)

19 August 2017

1 reference

title

Haploidentical SCT in children: an update and future perspectives (English)

1 reference

19 August 2017

P Lang

1

1 reference

19 August 2017

R Handgretinger

series ordinal

2

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

Bone Marrow Transplantation

19 August 2017

published in

1 reference

19 August 2017

volume

42 Suppl 2

1 reference

19 August 2017

page(s)

S54-9

1 reference

Determinants of antileukemia effects of allogeneic NK cells

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

Effect of HLA incompatibility in marrow transplantation from unrelated and HLA-mismatched related donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Transplantation of a combination of CD133+ and CD34+ selected progenitor cells from alternative donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Partially matched related donor peripheral blood progenitor cell transplantation in paediatric patients adding fludarabine and anti-lymphocyte gamma-globulin

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Long-term outcome after haploidentical stem cell transplantation in children

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Haploidentical transplantation for acute lymphoblastic leukemia in childhood

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Haploidentical stem cell transplantation for children with acute leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Feasibility and outcome of reduced-intensity conditioning in haploidentical transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Tolerance induction by 'megadose' transplants of CD34+ stem cells: a new option for leukemia patients without an HLA-matched donor.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Allogeneic CD34+ -selected peripheral stem cell transplantation from parental donors in children with non-malignant diseases

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

A large-scale method for T cell depletion: towards graft engineering of mobilized peripheral blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Determination of residual T- and B-cell content after immunomagnetic depletion: proposal for flow cytometric analysis and results from 103 separations

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Peripheral blood stem cell allograft rejection mediated by CD4(+) T lymphocytes recognizing a single mismatch at HLA-DP beta 1*0901

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Deficiency in the Wiskott-Aldrich protein induces premature proplatelet formation and platelet production in the bone marrow compartment

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

OKT-3-based reconditioning regimen for early graft failure in HLA-non-identical stem cell transplants

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Flow cytometry with anti HLA-antibodies: a simple but highly sensitive method for monitoring chimerism and minimal residual disease after HLA-mismatched stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for treatment of hematological malignancies in children

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Outcome of non-T-cell-depleted HLA-haploidentical hematopoietic stem cell transplantation from family donors in children and adolescents

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

A prospective analysis of the pattern of immune reconstitution in a paediatric cohort following transplantation of positively selected human leucocyte antigen-disparate haematopoietic stem cells from parental donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Haploidentical stem cell transplantation in leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

The role of haploidentical stem cell transplantation in the management of children with haematological disorders

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Antiviral activity against CMV-infected fibroblasts in pediatric patients transplanted with CD34(+)-selected allografts from alternative donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an update

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Preemptive Therapy of EBV-Related Lymphoproliferative Disease after Pediatric Haploidentical Stem Cell Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Adenovirus infection after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Current status of haploidentical stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Searching for alternative hematopoietic stem cell donors for pediatric patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Haploidentical stem cell transplantation in patients with pediatric solid tumors: preliminary results of a pilot study and analysis of graft versus tumor effects

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.285

7 January 2021

Identifiers

DOI

10.1038/BMT.2008.285

1 reference

19 August 2017

1 reference